Related Experiment Video

Updated: Apr 6, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations

D R Mould1, A-C Walz2, T Lave2

  • 1Projections Research Phoenixville, Pennsylvania, USA.

CPT: Pharmacometrics & Systems Pharmacology
|July 31, 2015
PubMed

Insights

Anticancer drug development can be improved by using modeling and simulation. Integrating these tools helps optimize anticancer agent dosing, enhancing clinical activity and reducing toxicity for better success rates.

Area of Science:

  • Pharmacology
  • Oncology
  • Drug Development

Background:

  • Anticancer agents frequently possess a narrow therapeutic index (TI), necessitating precise dosing to balance clinical efficacy with toxicity.
  • Complex pharmacology and combination therapies in cancer treatment can lead to schedule-specific effects and drug interactions.

Purpose of the Study:

  • To review anticancer drug development processes.
  • To demonstrate how modeling and simulation can inform anticancer dose selection.
  • To highlight the potential of these methods in improving late-phase clinical trial success rates.

Main Methods:

  • Review of existing literature and methodologies in anticancer drug development.
  • Integration of pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation principles.
  • Analysis of how these tools can guide dose selection and optimize treatment regimens.

Main Results:

  • Modeling and simulation can provide crucial insights into anticancer agent behavior.
  • These approaches can help predict and mitigate toxicity while ensuring therapeutic exposure.
  • Informed dose selection can potentially increase the success rate of late-phase anticancer drug development.

Conclusions:

  • Integrating modeling and simulation throughout anticancer drug development is essential.
  • These methods offer a powerful strategy for optimizing dose selection and improving clinical outcomes.
  • This approach holds promise for enhancing the efficiency and success of bringing new anticancer therapies to patients.

More Related Videos

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
117
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
69
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
212
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K